NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT.
Pediatr Blood Cancer
; 59(4): 739-42, 2012 Oct.
Article
in En
| MEDLINE
| ID: mdl-22180305
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Killer Cells, Natural
/
Adrenal Gland Neoplasms
/
Hematopoietic Stem Cell Transplantation
/
Immunotherapy
/
Neuroblastoma
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
/
Male
Language:
En
Journal:
Pediatr Blood Cancer
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2012
Type:
Article
Affiliation country:
France